Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging

Karen Chen; Judy Blebea; Jean Denis Laredo; Wengen Chen; Abass Alavi; Drew A. Torigian

doi:10.1016/j.cpet.2009.03.003

Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging

Karen Chen, Judy Blebea, Jean Denis Laredo, Wengen Chen, Abass Alavi, Drew A. Torigian

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

18F-2-fluoro-2-deoxy-D-glucose-PET has an established role in the evaluation of hip periprosthetic infection and musculoskeletal malignancies. Determination of its role in the management of inflammatory arthritis and diabetic foot complications is ongoing. The reintroduction of fluorine F 18 sodium fluoride as a PET radiotracer may advantageously replace technetium Tc 99 m methylene diphosphonate for some non-oncologic applications, including treatment monitoring of Paget's disease andfibrous dysplasia. The combination of CT or MR imaging with PET imaging synergistically maximizes the diagnostic potential of a combined structural-functional imaging approach for the detection, characterization, and monitoring of myriad musculoskeletal disorders.

Original language	English
Pages (from-to)	451-465
Number of pages	15
Journal	PET Clinics
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/j.cpet.2009.03.003
State	Published - Jul 2008

Keywords

Arthroplasty
Diabetic foot
Metabolic bone disease
Musculoskeletal
Oncology
PET/CT
PET/MRI
Positron emission tomography (PET)

Access to Document

10.1016/j.cpet.2009.03.003

Cite this

@article{553db26c27c04fac9014b599f3b7f02d,

title = "Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging",

abstract = "18F-2-fluoro-2-deoxy-D-glucose-PET has an established role in the evaluation of hip periprosthetic infection and musculoskeletal malignancies. Determination of its role in the management of inflammatory arthritis and diabetic foot complications is ongoing. The reintroduction of fluorine F 18 sodium fluoride as a PET radiotracer may advantageously replace technetium Tc 99 m methylene diphosphonate for some non-oncologic applications, including treatment monitoring of Paget's disease andfibrous dysplasia. The combination of CT or MR imaging with PET imaging synergistically maximizes the diagnostic potential of a combined structural-functional imaging approach for the detection, characterization, and monitoring of myriad musculoskeletal disorders.",

keywords = "Arthroplasty, Diabetic foot, Metabolic bone disease, Musculoskeletal, Oncology, PET/CT, PET/MRI, Positron emission tomography (PET)",

author = "Karen Chen and Judy Blebea and Laredo, {Jean Denis} and Wengen Chen and Abass Alavi and Torigian, {Drew A.}",

year = "2008",

month = jul,

doi = "10.1016/j.cpet.2009.03.003",

language = "English",

volume = "3",

pages = "451--465",

journal = "PET Clinics",

issn = "1556-8598",

number = "3",

}

TY - JOUR

T1 - Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging

AU - Chen, Karen

AU - Blebea, Judy

AU - Laredo, Jean Denis

AU - Chen, Wengen

AU - Alavi, Abass

AU - Torigian, Drew A.

PY - 2008/7

Y1 - 2008/7

N2 - 18F-2-fluoro-2-deoxy-D-glucose-PET has an established role in the evaluation of hip periprosthetic infection and musculoskeletal malignancies. Determination of its role in the management of inflammatory arthritis and diabetic foot complications is ongoing. The reintroduction of fluorine F 18 sodium fluoride as a PET radiotracer may advantageously replace technetium Tc 99 m methylene diphosphonate for some non-oncologic applications, including treatment monitoring of Paget's disease andfibrous dysplasia. The combination of CT or MR imaging with PET imaging synergistically maximizes the diagnostic potential of a combined structural-functional imaging approach for the detection, characterization, and monitoring of myriad musculoskeletal disorders.

AB - 18F-2-fluoro-2-deoxy-D-glucose-PET has an established role in the evaluation of hip periprosthetic infection and musculoskeletal malignancies. Determination of its role in the management of inflammatory arthritis and diabetic foot complications is ongoing. The reintroduction of fluorine F 18 sodium fluoride as a PET radiotracer may advantageously replace technetium Tc 99 m methylene diphosphonate for some non-oncologic applications, including treatment monitoring of Paget's disease andfibrous dysplasia. The combination of CT or MR imaging with PET imaging synergistically maximizes the diagnostic potential of a combined structural-functional imaging approach for the detection, characterization, and monitoring of myriad musculoskeletal disorders.

KW - Arthroplasty

KW - Diabetic foot

KW - Metabolic bone disease

KW - Musculoskeletal

KW - Oncology

KW - PET/CT

KW - PET/MRI

KW - Positron emission tomography (PET)

UR - http://www.scopus.com/inward/record.url?scp=67249147368&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2009.03.003

DO - 10.1016/j.cpet.2009.03.003

M3 - Review article

AN - SCOPUS:67249147368

SN - 1556-8598

VL - 3

SP - 451

EP - 465

JO - PET Clinics

JF - PET Clinics

IS - 3

ER -

Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this